Phlebotonics for venous insufficiency

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 11, 2020, Pages

  Martinez Zapata, Maria José ^a   Vernooij, Robin WM ^b   Simancas Racines, Daniel ^c   Uriona Tuma, Sonia Maria ^d   Stein, Airton T ^e   Moreno Carriles, Rosa Maria M ^f   Vargas, Emilio ^g   Bonfill Cosp, Xavier ^h  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c School of Engineering Sciences and Industry   (Ecuador)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINAPHTHONE; CENTELLA ASIATICA EXTRACT; DIOSMIN; DOBESILATE CALCIUM; GRAPE SEED EXTRACT; HIDROSMINE; PLACEBO; RUTOSIDE; UNCLASSIFIED DRUG; VASOACTIVE AGENT; 4 AMINOBENZOIC ACID; 4 AMINOBENZOIC ACID DERIVATIVE; HEMATOLOGIC AGENT; HIDROSMIN; PLANT EXTRACT;

ALLERGIC REACTION; ANKLE CIRCUMFERENCE; CALF CIRCUMFERENCE; CHRONIC VEIN INSUFFICIENCY; COLIC; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPIGASTRIC DISCOMFORT; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEARTBURN; HUMAN; LEG CRAMP; LEG EDEMA; LEG PAIN; LEG SWELLING; NAUSEA; NEUROLOGIC DISEASE; PARESTHESIA; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH PAIN; SYSTEMATIC REVIEW; ULCER HEALING; VOMITING; XEROSTOMIA; ANGIONEUROTIC EDEMA; CENTELLA; CHRONIC DISEASE; EDEMA; LEG; LEG ULCER; META ANALYSIS; MIDDLE AGED; PHYTOTHERAPY; PINE; PROCEDURES; VEIN INSUFFICIENCY;

4-AMINOBENZOIC ACID; ANGIOEDEMAS, HEREDITARY; CALCIUM DOBESILATE; CENTELLA; CHRONIC DISEASE; DIOSMIN; EDEMA; HEMATOLOGIC AGENTS; HUMANS; LEG; LEG ULCER; MIDDLE AGED; PARA-AMINOBENZOATES; PHYTOTHERAPY; PINUS; PLANT EXTRACTS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RUTIN; VENOUS INSUFFICIENCY;

EID: 85095667516     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003229.pub4     Document Type: Review

References (251)

1. Allegra C Pollari G, Criscuolo A, Bonifacio M, Tabassi D. Centella asiatica extract in venous disorders of the lower limbs. Comparative clinico-instrumental studies with a placebo. Clinica Terapeutica 1981;99(5):507-13. x-wiley/crsRef/3431426
2. Alterkamper H. Efficacy of antivaricotic drugs can be measured objectively. Phlebologie in der Praxis 1987;2(9-10):19-20. x-wiley/crsRef/3431428
3. Arcangeli P. Pycnogenol in chronic venous insufficiency. Fitoterapia 2000;71(3):236-44. x-wiley/crsRef/3431430
4. Balmer A, Limoni C. Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients. Vasa 1980;9(1):76-82. x-wiley/crsRef/3431432
5. Blume J. Therapy of venous oedemas [Tratamento do edema de origem venosa]. Revista Brasileira de Medicina 1994;51(3):283-8. x-wiley/crsRef/3431433
6. Belczak SQ, Sincos IR, Campos W, Beserra J, Nering G, Aun R. Veno-active drugs for chronic venous disease: a randomized, double-blind, placebo-controlled parallel-design trial. Phlebology 2014;29(7):454-60. x-wiley/crsRef/3431435
7. Berqvist D, Hallböök T, Lindblad B, Lindhagen A. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency. Vasa 1981;10(3):253-60. x-wiley/crsRef/3431437
8. Biland L, Blättler P, Scheibler P, Studer S, Widmer K. Zur therapie sogenannt venosër beinsbeschwerden. Vasa 1982;11(1):53-8. x-wiley/crsRef/3431439
9. Burnand KG, Powell S, Bishop C, Stacey M, Pulvertaft T. Effect of Paroven on skin oxygenation in patients with varicose veins. Phlebologie 1989;4(1):15-22. x-wiley/crsRef/3431441
10. Casley-Smith JR. A double-blind, placebo -controlled, matched-pair trial of the mode of action of 'Doxium' in the treatment of chronic venous insufficiency. In: Davy A and Stemmer R, editors(s). Proceedings of the Union Internationale de Phlebologie - 10th World Congress, Strasbourg, 25-29 September. London and Paris: John Libbey Eurotext Ltd, 1989. x-wiley/crsRef/3431444
11. Casley-Smith JR. A double-blind, placebo-controlled, matched-pair trial of the mode of action of 'Doxium' in the treatment of chronic venous insufficiency. Phlebologie 1989;2:709-11. x-wiley/crsRef/3431445
12. Casley-Smith JR. A double-blind trial of calcium dobesilate in chronic venous insufficiency. Angiology 1988;39(10):853-7. x-wiley/crsRef/3431443
13. Van Cauwenberge H. Double-blind study of the efficacy of a soluble rutoside derivative in the treatment of venous disease. Archives of Internal Pharmacodynamics and Therapeutics 1972;196(Suppl 196):122-5. x-wiley/crsRef/3431447
14. Van Cauwenberge H. Double-blind clinical trial to assess the efficacy of 0-(b-hidroxy-ethyl)-rutosides in the treatment of venous disorders [Etude en double aveugle de l'efficacité de l'0-(b-hidroxyéthyl)-rutosides dans le traitement des affections veineuses]. Mèdicine et Hygiène 1978;35:4175-7. x-wiley/crsRef/3431449
15. Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Griffin M, Ippolito E, et al. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; O-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. Journal of Cardiovascular Pharmacology and Therapeutics 2002;7 Suppl 1:S21-4. x-wiley/crsRef/3431451
16. Chassignolle JF, Amiel M, Lanfranchi G, Barbe R. Activite therapeutique de daflon 500 mg dans l'insuffisance veineuse fonctionnelle. Journal International de Medicine 1994;Suppl 99:32-5. x-wiley/crsRef/3431453
17. Cloarec M, Clement R, Griton P, Guillou GB, Golden G. A double blind three centre trial on efficacy of o-(beta-hydroxyethyl) rutosides in patients with venous insufficiency. International Angiology 1994;13 Suppl 1(2):74. x-wiley/crsRef/3431455
18. Cloarec M, Clément R, Griton P. A double-blind clinical trial of hydroxyethylrutosides in the treatment of the symptoms and signs of chronic venous insufficiency. Phlebology 1996;11(2):76-82. x-wiley/crsRef/3431457
19. Cornu-Thenard A, Dahan B, De Parades B. Study of the action in venous insufficiency of the legs. Pierre Fabre Medicament Laboratoires (Novartis). Report no. DC982GEC51(2), 1985. x-wiley/crsRef/3431459
20. Danielsson G, Jungbeck C, Peterson K, Norgren L. A randomised controlled trial of micronised purified flavonoid fraction versus placebo in patients with chronic venous disease. European Journal of Vascular and Endovascular Surgery 2002;23(1):73-6. x-wiley/crsRef/3431461
21. Diebschlag W, Nocker W, Lehmacher W, Rehn D. A clinical comparison of two doses of O-(beta-hydroxyethyl) rutosides (oxerutins) in patients with chronic venous insufficiency. Journal of Pharmaceutical Medicine 1994;4(1):7-14. x-wiley/crsRef/3431463
22. Fundación Iberoamericana Itaca. Randomized, double-blind multicenter clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of ulcer secondaries to chronic venous disease. ClinicalTrials.gov 2009. x-wiley/crsRef/3431465
23. Dominguez C, Brautigham I, González E, González JA, Nazco J, Valiente R, et al. Therapeutic effects of hidrosmin on chronic venous insufficiency of the lower limbs. Current Medical Research and Opinion 1992;12(10):623-30. x-wiley/crsRef/3431467
24. Fermoso J, Legido AG, Del Pino J, Valiente R. Therapeutic value of hidrosmin in the treatment of venous disorders of the lower limbs. Current Therapeutic Research, Clinical and Experimental 1992;52(1):124-34. x-wiley/crsRef/3431469
25. Flota-Cervera F, Flota-Ruiz C, Treviño C, Berber A. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease. Angiology 2008;59(3):352-6. x-wiley/crsRef/3431472
26. Flota LF. Prospective, randomised, double-blind, placebo controlled, clinical trial that assesses the efficacy of calcium dobesilate in the limphoedema by varicose disease [Estudio clínico prospectivo aleatorizado, doble ciego, con control placebo, para evaluar la eficacia en la resolución del edema de origen lifático, del dobesilato de calcio en pacientes con enfermedad varicosa]. Knoll de Mexico S.A. Laboratorios Dr. Esteve. No de proyec. Knoll-mex-02-99, 003/MEX, 99. x-wiley/crsRef/3431471
27. Frileux C, Gilly R. Activité thérapeutic de Daflon 500 mg dans l'insuffisance veineuse chronique des membres inférieurs. Journal Internationale de Medicine 1994;Suppl 99:36-9. x-wiley/crsRef/3431474
28. Gilly R, Pillion G, Frileux C. Evaluation of a new venactive micronized flavonoid fraction (S5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: a double-blind, placebo-controlled study. Phlebology 1994;9(2):67-70. x-wiley/crsRef/3431475
29. Thiollet M, Frileux C, Gilly R. Evaluation of a new micronized diosmin in the treatment of chronic venous incompetence: a double-blind, placebo controlled trial. Journal of Vascular Surgery 1992;15(2):447. x-wiley/crsRef/3431476
30. Guilhou JJ, Dereure O, Marzin L, Ouvry P, Zuccarelli F, Debure C, et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomised, controlled versus placebo trial in 107 patients. Angiology 1997;48(1):77-85. x-wiley/crsRef/3431478
31. Hachen HJ, Lorenz P. Double-blind clinical and plethysmographic study of calcium dobesilate in patients with peripheral microvascular disorders. Angiology 1982;33(7):480-8. x-wiley/crsRef/3431480
32. Ihme N, Kiesewetter H, Jung F, Hoffmann KH, Birk A, Müller A, et al. Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomized, double-blind, placebo-controlled clinical trial. European Journal of Clinical Pharmacology 1996;50(6):443-7. x-wiley/crsRef/3431482
33. De Jongste AB, Ten Cate JW, Huisman MV. The effectiveness of o-(b-hydroxyethyl)-rutosides (HR) in the post-thrombotic syndrome (PTS). Phlebology 1986;85 Suppl 285:837-9. x-wiley/crsRef/3431484
34. Jongste AB, Jonker JJC, Huisman MV, Cate JW, Azar AJ. A double-blind trial on the short-term efficacy of HR in patients with the post-thrombotic syndrome. Phlebology 1990;5(Suppl 1):21-2. x-wiley/crsRef/3431486
35. Jongste AB, Jonker JJC, Huisman MV, den Cate JW, Azar AJ. A double-blind three center clinical trial on the short-term efficacy of O-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome. Thrombosis and Haemostasis 1989;62(3):826-9. x-wiley/crsRef/3431487
36. Kiesewetter H, Koscielny J, Grützner K, Müller A, Hoffmann KH, Birk A. Buckwheat herb/troxerutin-combination for the treatment of chronic venous insufficiency. Zeitschrift für Phytotherapie 1997;18(6):341-6. x-wiley/crsRef/3431489
37. Klüken N. Double-blind clinical trial to assess the therapy with drugs for venous disorders [Estudio clínico doble ciego para tratar de objetivar la terapéutica con venofármacos]. Therapiewoche 1971;21:1. x-wiley/crsRef/3431491
38. Koscielnny J, Radtke H, Hoffmann, Jung F, Müller A, Grützner KI, et al. Fagorutin buckwheat herb tea in chronic venous insufficiency. Zeitschrift für Phytotherapie 1996;17(3):147-59. x-wiley/crsRef/3431493
39. Kriner E, Braun R, Hirche H, Van Laak HH. Treatment of venous insufficiency. A double-blind trial with Phlebodril. Zeitschrift für Allgemeinmedizin 1985;61(9):309-13. x-wiley/crsRef/3431495
40. Jaeger K. Efficacy and safety of doxium in chronic venous insufficiency. Double-blind, placebo-controlled multicentre study. International Angiology 2001;20(2 Suppl 1):239. x-wiley/crsRef/3431497
41. Jaeger K. Efficacy and safety of doxium in chronic venous insufficiency. OM PHARMA (LAB. ESTEVE). Study number: DX-1994/2. x-wiley/crsRef/3431498
42. Labs KH, Degischer S, Gamba G, Jaeger KA, on behalf of the CVI Study Group. Effectiveness and safety of calcium dobesilate in treating chronic venous insufficiency: randomized, double-blind, placebo-controlled trial. Phebology 2004;19(3):123-9. x-wiley/crsRef/3431499
43. Languillat N. Trial of Cyclo 3 Fort in venous insufficiency of the lower limbs: Xenon 133 functional investigation of venous circulatory velocity. Pierre Fabre Medicament Laboratories (Novartis). No. Report DC982GEC130(2), 1988. x-wiley/crsRef/3431501
44. Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg. International Angiology 1988;7(2 Suppl):39-43. x-wiley/crsRef/3431503
45. Lazzarini A, Danieli L. Clinical controlled trial of aminaphtone in lower limbs' phlebopathies and phlebopathic ulcers [Sperimentazione clinica controllata del l´aminaftone flebopatie degli arti inferiori e nelle flebopatiche]. Rassegna Internazionale di Clinica e Terapia 1982;62(12):825-44. x-wiley/crsRef/3431505
46. Dikland WJ. A clinical trial on the effect of hydroxyethylrutosides on venous refilling time as measured by light reflection rheography. Scripta Phlebologica 1995;3:4-7. x-wiley/crsRef/3431507
47. MacLennan WJ, Wilson J, Rattenhuber V, Dikland WJ, Vanerdonckt J, Moriau M. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency. Its efficacy and tolerability. Gerontology 1994;40(1):45-52. x-wiley/crsRef/3431508
48. Mann RJ. A double-blind trial of oral O-beta-hydroxyethyl rutosides for stasis leg ulcers. British Journal of Clinical Practice 1981;35:79-81. x-wiley/crsRef/3431510
49. Marinello J, et al. Multicentric, randomised, double-blind, placebo controlled, clinical trial that assess the efficacy of calcium dobesilate in the treatment of venous hypertension in patients with chronic venous insufficiency [Ensayo clínico multicéntrico, doble ciego, aleatorizado, controlado con placebo sobre la eficacia de dobesilato de calcio en el tratamiento de la hipertensión venosa en pacientes afectos de insuficiencia venosa crónica en sus extremidades inferiores. Código: ESCLIN-004/99]. Laboratorios Dr. Esteve. x-wiley/crsRef/3431513
50. Marinello J, Videla S. Chronic venous insufficiency of the lower limbs: suitability of transcutaneous blood gas monitoring as an endpoint to evaluate the outcome of pharmacological treatment with calcium dobesilate. Methods and Findings in Experimental and Clinical Pharmacology 2004;26(10):775-80. x-wiley/crsRef/3431512
51. Martinez-Zapata MJ, Moreno RM, Gich I, Urrútia G, Bonfill X, Chronic Venous Insufficiency Study Group. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease. European Journal of Vascular and Endovascular Surgery 2008;35(3):358-65. x-wiley/crsRef/3431515
52. NCT01848210. Efficacy and safety of coumarin and troxerutin in the symptomatic treatment of chronic venous insufficiency. clinicaltrials.gov/ct2/show/NCT01848210 (first posted 7 May 2013). x-wiley/crsRef/3431921
53. Nocker W, Diebschlag W, Lehmacher W. Clinical trials of the dose-related effects of o-(beta-hydroxyethyl)-rutosides in patients with chronic venous insufficiency. Phlebology 1990;5 Suppl 1:23-6. x-wiley/crsRef/3431517
54. Nocker W, Diebschlag W, Lehmacher W. Three-month, randomized, double-blind, dose-response study with O-(beta-hydroxyethyl)-rutosides drinking solution. Vasa 1989;18(3):235-8. x-wiley/crsRef/3431518
55. Nocker W, Diebschlag W. An investigation of dosage effects with drinking solutions of o-(beta hydroxyethyl)-rutosides. Vasa 1987;16:365-9. x-wiley/crsRef/3431519
56. Padrós W. Controlled study of the effect of calcium dobesilate on syndromes of venous insufficiency. Medicina Clínica 1972;58(6):515-9. x-wiley/crsRef/15204504
57. Padros W. Double blind investigation of clinical effectiveness of calcium dobesilate in the venous insufficiency syndrome (Dutch). Ars Medici Internationaal Tijdschrift voor Praktische Therapie 1977;6(8):777-84. x-wiley/crsRef/15204505
58. Padros W. Double blind study of the action of calcium dobesilate on venous insufficiency syndromes. Ars Medici Revue Internationale de Therapie Pratique 1977;32(8):783-90. x-wiley/crsRef/15204506
59. Parrado F, Buzzi A. A study of the efficacy and tolerability of a preparation containing Ruscus aculeatus in the treatment of chronic venous insufficiency of the lower limbs. Clinical Drug Investigation 1999;18(4):255-61. x-wiley/crsRef/3431525
60. Pecchi S, De Franco V, Damiani P, Guerrini M, Di Perri T. Calcium dobesilate in the treatment of primary venous insufficiency of the lower limbs. A controlled clinical study [Il dobesilato di calcio nel trattamento del l´insufficienza venosa primitiva degli arti inferiori]. Clinica Terapeutica 1990;132(6):409-17. x-wiley/crsRef/3431527
61. Pedersen FM, Hamberg O, Sorensen MD, Neland K. The effect of O-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs. Ugeskrift for Laeger 1992;154(38):2561-3. x-wiley/crsRef/3431529
62. Petrassi C, Mastromarino A, Spartera C. Pycnogenol in chronic venous insufficiency. Phytomedicine 2000;7(5):383-8. x-wiley/crsRef/3431531
63. Planchon B. Venous insufficiency and Daflon 500 mg [Insuffisance veineuse et Daflon 500 mg]. Artères et Veines 1990;IX(4):376-80. x-wiley/crsRef/3431533
64. Pointel JP, Boccalon H, Cloarec M, Le Devehat C, Joubert M. Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 1987;38(1 Pt 1):46-50. x-wiley/crsRef/3431535
65. Pointel JP. Titrated extract of centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 1986;37(5):420-1. x-wiley/crsRef/3431536
66. Prerovsky I, Roztocil K, Hlavova A, Koleilat Z, Razgova L, Oliva I. The effects of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double blind study. Angiologica 1972;9(3-6):408-14. x-wiley/crsRef/3431538
67. Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK. Vasa 1983;12(4):373-6. x-wiley/crsRef/3431540
68. Pulvertaft TB. Paroven in the treatment of chronic venous insufficiency. Practitioner 1979;223(1338):838-41. x-wiley/crsRef/3431541
69. Rabe E, Jaeger KA, Bulitta M, Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial. Phlebology 2011;26:162–8. x-wiley/crsRef/3431543
70. Rabe E, Agus GB, Roztocil K. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial. International Angiology 2015;34(5):428-36. x-wiley/crsRef/15204508
71. Rabe E, Ballarini S, Lehr L, Doxium EDX09/01 Study Group. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency. Phlebology 2016;31(4):264-74. x-wiley/crsRef/15204510
72. Renton S, Leon M, Belcaro G, Nicolaides AN. The effect of hydroxyethylrutosides on capillary filtration in moderate venous hypertension: a double blind study. International Angiology 1994;13(3):259-62. x-wiley/crsRef/3431545
73. Rose SS. A report on the use of an hydroxyethylrutoside in symptoms due to venous back pressure and allied conditions in the lower limbs. British Journal of Clinical Practice 1970;24(4):161-4. x-wiley/crsRef/3431547
74. Rudofsky G, Diehm C, Grub J, Hartmann M, Schultz-Ehrenburg HU, Bisler H. Ruscus saponines and the flavonoid hesperidinmethylchalcone in the treatment of chronic venous insufficiency. In: Davy A, Stemmer R, editors(s). Proceedings of the Union Internationale de Phlebologie - 10th World Congress, Strasbourg, 25-29 September. London and Paris: John Libbey Eurotext Ltd, 1989:728-30. x-wiley/crsRef/3431549
75. Rudofsky G, Diehm C, Gruss JD, Hartman M, Schultz-Ehrenburg HK, Bisler H. Chronic venous insufficiency: treatment with Ruscus extract and trimethyl hesperidine chalcone. Münchener Medizinische Wochenschrift 1990;132(13):205-10. x-wiley/crsRef/3431550
76. Schultz-Ehrenburg U, Müller B. Two multicentre clinical trials of two different dosages of O-(beta-hydroxyethyl)-rutosides in the treatment of leg ulcers. Phlebology 1993;8 Suppl 1:29-30. x-wiley/crsRef/3431552
77. Sentou Y. Double blind study of the activity of Cyclo 3 in man. International Angiology 1984;3:106-9. x-wiley/crsRef/3431554
78. Serralde CF, Aceves AQ. Clinical trial of the O-(β-hydroxy-ethyl-rutosides) in patients with chronic venous insufficiency [Ensayo clínico de o-(beta-hidroxietil-rutósidos) en pacientes con insuficiencia venosa crónica]. Revista Médica del Hospital General de México 1990;53(2):102-6. x-wiley/crsRef/3431556
79. Thebaut JF, Thebaut P, Vin F. Trial of vasculoprotective agent (plant products of the flavan class) in functional manifestations of peripheral venous insufficiency (double-blind trial in 92 cases). Gazette Medicale 1985;92(12):96-100. x-wiley/crsRef/3431558
80. Tsouderos Y. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency. Our experience with Daflon 500 mg. International Angiology 1989;8(4):53-9. x-wiley/crsRef/3431560
81. Tsouderos Y. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg. Zeitschrift fur Kardiologie 1991;80 Suppl 7:95-101. x-wiley/crsRef/3431561
82. Unkauf M, Rehn D, Klinger J, Motte S, Grobmann K. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings. Arzneimittel-Forschung 1996;46(5):478-82. x-wiley/crsRef/3431563
83. Vanscheidt W, Rabe E, Naser-Hijazi B, Ramelet AA, Partsch H, Diehm C, et al. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study. Vasa 2002;31(3):185-90. x-wiley/crsRef/3431565
84. Vanscheidt W, Jost V, Wolna P, Lücker A, Muller A, Theurer C, et al. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency. Arzneimittel-Forschung 2002;52(4):243-50. x-wiley/crsRef/3431567
85. Vin E, Chabanel A, Taccoen A, Ducros J, Grufaz J, Hutinel B, et al. Action of Veinamitol 3500 mg on clinical and hemorheological data in CVI. International Angiology 1995;14(Suppl 1):99. x-wiley/crsRef/3431569
86. Vin F, Chabanel A, Taccoen A, Ducros J, Gruffaz J, Hutinel B, et al. Action de la troxérutine sur les paramètres cliniques, pléthysmographiques et rhéologiques de l'insuffisance veineuse des membres inférieurs. Etude contrôlée contre placebo. Artères et Veines 1992;XI:333-42. x-wiley/crsRef/3431570
87. Vin F, Chabanel A, Taccoen A, Ducros J, Gruffaz J, Hutinel B, et al. Double-blind trial of the efficacy of troxerutin in chronic venous insufficiency. Phlebology 1994;9(2):71-6. x-wiley/crsRef/3431571
88. Welch W, Moriau M, van Gysel JP. A double-blind, placebo controlled trial of o-(beta-hydroxyethyl)-rutosides in patients with chronic venous insufficiency. Novartis 1985. x-wiley/crsRef/3431573
89. Widmer L, Biland L, Barras JP. Doxium 500 in chronic venous insufficiency: a double-blind placebo controlled multicentre study. International Angiology 1990;9(2):105-10. x-wiley/crsRef/3431575
90. Zucarelli F. Clinical efficacy and tolerability of rutin. Double blind, placebo controlled clinical trial. [Efficacité clinique et tolerance de la coumarine rutine. Étude controlée en double aveugle versus placebo]. Gazette Médicale 1987;94(32):80-6. x-wiley/crsRef/3431577
91. Akbulut B. Calcium dobesilate and oxerutin: effectiveness of combination therapy. Phlebology 2010;25:66-71. x-wiley/crsRef/3431579
92. Androulakis G, Panoysis PA. Plethysmographic confirmation of the beneficial effect of calcium dobesilate in primary varicose veins. Angiology 1989;40(1):1-4. x-wiley/crsRef/3431585
93. Auteri A, Blardi P, Frigerio C, de Lillo L, di Perri T. Pharmacodynamics of troxerutine in patients with chronic venous insufficiency: correlations with plasma drug levels. International Journal of Clinical Pharmacology Research 1990;10(4):235-41. x-wiley/crsRef/3431587
94. Bacci PA, Allegra C, Botta G, Mancini S. The role of a multifunctional plant complex in phlebolymphology: randomized, placebo-controlled double-blind clinical study. Amercian College of Phlebology. Abstracts from the 17th Annual Congress, August 27 - 31, 2003 — San Diego, California. x-wiley/crsRef/3431591
95. Bastide G, Becade P, Goulley Y. Double blind study of Dihydroergotamine Sandoz in venous pathology of lower limbs. Angeiologie 1976;28(5):249-54. x-wiley/crsRef/3431593
96. Batchvarova V. Effet Clinique du Troxevit sur l'Insuffisance Veineuse Chronique. Vol. 2. London & Paris: John Libby Eurotext Ltd, 1989. x-wiley/crsRef/3431597
97. Behar A, Nathan P, Lavieuville M, Allaert FA. Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas. Phlébologie 1993;46(4):721-31. x-wiley/crsRef/3431599
98. Belcaro G, Rulo A, Candiani C. Evaluation of the microcirculatory effects of Venorutin in patients with chronic venous hypertension by laser Doppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements. Vasa 1989;18:146-51. x-wiley/crsRef/3431603
99. Belcaro G, Rulo A, Candiani C. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laser-Doppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements. Phlebology 1989;4(1):23-30. x-wiley/crsRef/3431604
100. Belcaro G, Rosaria Cesarone M, De Sanctis MT, Incandela L, Laurora G, Fevrier B, et al. Laser doppler and transcutaneous oxymetry: modern investigations to assess drug efficacy in chronic venous insufficiency. International Journal of Microcirculation: Clinical and Experimental 1995;15(Suppl 1):45-9. x-wiley/crsRef/3431606
101. Belcaro G Cesarone MR, Ledda A, Cacchio M, Ruffini I, Ricci A, et al. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Angiology 2008;59 (Suppl 1):7S-13S. x-wiley/crsRef/3431613
102. Bello AA, Meyer K, Garcia AT, Reinaga VV. Calcium dobesilate combined with a heparinoid in the topical treatment of chronic venous insufficiency: a double-blind study. Acta Therapeutica 1990;16(1):79-87. x-wiley/crsRef/3431617
103. Bento C, Brandão DDC, Smith P. A multicentric, IV phase, multidisciplinary, prospective, randomized, double blinded, comparative study to evaluate the castanha-da-índia, rutina, smilax japicanga and polygonum punctatum combination efficacy and tolerability in the treatment of patients suffering from symptomatic venous insufficiency comparing to placebo treatment. Revista Brasileira de Medicina 2006;63(8):422-6. x-wiley/crsRef/3431622
104. Berson I. About a new medicamentous treatment of the varicose syndrome. Schweiz Rundschau Med (PRAXIS) 1978;67:981-3. x-wiley/crsRef/3431626
105. Blume J, Wüstenberg P. Chronic vein insufficiency. Treatment results with benzopyrones during and after compression therapy [Cronisch-venöse Insuffizienz (CVI). Behandlungsergebnisse mit benzopyronen und nach Kompressiontherapie]. Therapiewoche 1996;46(10):540-4. x-wiley/crsRef/3431630
106. Blume J. Therapy of venous oedema [Tratamento do edema de origem venosa. Eficácia de um tratamento medicamentoso em combinaçao com o tratamento compresivo]. Revista Brasileira de Medicina 1994;51(3):283-8. x-wiley/crsRef/3431631
107. Bohm C. Venodiuretics: a new combination of diuretic and edema protective drugs. Medizinische Welt 1989;40(30-31):887-8. x-wiley/crsRef/3431635
108. Boisseau MR, Taccoen A, Garreau C, Vergnes C, Roudaut MF, Garreau-Gomez B. Fibrinolysis and hemorheology in chronic venous insufficiency: a double-blind study of troxerutin efficiency. Journal of Cardiovascular Surgery 1995;36(4):369-74. x-wiley/crsRef/3431637
109. Bolliger AA. Results of a double blind trial of percutaneously administered rutoside. Angiologica 1972;9:397-400. x-wiley/crsRef/3431639
110. Bort H, Hahn M, Klyscz T, Junger M. The influence of rutosides on increased capillary permeability in chronic venous insufficiency as measured by video capillaroscopy. In: Proceedings of the Union Internationale de Phlebologie - 12th World Congress, London, 3-8 September. 1995. x-wiley/crsRef/3431641
111. Bosse K, Drieschner P, Klose L. Comparative studies concerning the effectiveness of therapeutic agents in chronic venous insufficiency. Phlebologie und Proktologie 1985;14:111-4. x-wiley/crsRef/3431643
112. Brami C, Morere MCNK, Megret G, Elbaz C. Double-blind controlled trial against placebo of dihydroergocryptine mesilate plus caffeine in chronic venous insufficiency. Angeiologie 1983;35(8):281-3. x-wiley/crsRef/3431645
113. Carstens C, Hampel H. Treatment of oedemata in chronic venous insufficiency by means of an additional therapy with DIU Venostatin. Die Medizinische Welt 1985;36:867-70. x-wiley/crsRef/3431651
114. Cataldi A, Gasbarro V, Viaggi R, Soverini R, Gresta E, Mascoli F. Effectiveness of the association of alphatocopherol, rutin, melilotus and centella asiatica in the treatment of patients affected by chronic venous insufficiency [Efficacia clinica di un'associazine di alfatocoferoli, rutina, meliloto e centella asiatica nel trattamento di pazienti con insufficienza venosa cronica]. Minerva Cardioangiologica 2001;49(2):159-63. x-wiley/crsRef/3431653
115. Cesarone MR, Laurora G, Ricci A, Belcaro G, Pomante P, Candiani C, et al. Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Vasa 1992;21(1):76-80. x-wiley/crsRef/3431655
116. Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Grimaldi R, Marelli C, et al. Microcirculatory activity of centella asiatica in venous insufficiency. Minerva Cardioangiologica 1994;42(6):299-304. x-wiley/crsRef/3431657
117. Cesarone MR, De Sanctis MT, Incandela L, Belcaro G, Griffin M, Bavera P, et al. Microvascular changes in venous hypertension due to varicose veins after standardized application of Essaven gel--a placebo-controlled, randomized study. Angiology 2001;52 Suppl 3:S11-6. x-wiley/crsRef/3431659
118. Cesarone MR, Belcaro G, De Sanctis MT, Incandela L, Cacchio M, Bavera P, et al. Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. Angiology 2001;52 Suppl 2:S15–8. x-wiley/crsRef/3431661
119. Cesarone MR, Incandela L, Belcaro G, Sanctis MT, Ricci A, Griffin M. Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy: a placebo-controlled, randomized study. Angiology 2001;52 Suppl 3:S43-8. x-wiley/crsRef/3431663
120. Cesarone MR, Belcaro G, Rulo A, Griffin M, Ricci A, Ippolito E, et al. Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry 93. Angiology 2001;52 Suppl 2:S45-8. x-wiley/crsRef/3431665
121. Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Dugall M, Acerbi G. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; O-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial. Journal of Cardiovascular Pharmacology and Therapeutics 2002;7 Suppl 1:S25-8. x-wiley/crsRef/3431673
122. Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G, et al. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study. Phytomedicine 2010;17(11):835-9. x-wiley/crsRef/3431689
123. Chant AD. The effect of paroven (HR) of the clearance of sodium-24 from the subcutaneous tissues of the foot in patients with varicose veins. Vasa 1973;2(3):288-91. x-wiley/crsRef/3431691
124. Chiummariello S, De Gado F, Monarca C, Ruggiero M, Carlesimo B, Scuderi N, et al. [Multicentric study on a topical compound with lymph-draining action in the treatment of the phlebostatic ulcer of the inferior limbs]. Il Giornale di chirurgia 2009;30(11-12):497-501. x-wiley/crsRef/3431693
125. Clemens S, Bisler H, Braun R. Phlebodril: Influences on the venous regurgitation. Phlebologie und Proktologie 1986;15(1):15-9. x-wiley/crsRef/3431695
126. Cospite M, Milio G. Heparan sulfate vs diosmin: effects on microcirculation in chronic venous insufficiency of the lower extremities. Advances in Therapy 1996;13(3):178-190. x-wiley/crsRef/3431699
127. De Anna D, Mari F, Intini S, Gasbarro V, Sortini A, Pozza E, et al. Effects of therapy with aminaftone on chronic venous and lymphatic stasis [Effetti della terapia con aminaftone sulla stasi venosa e linfatica cronica]. Minerva Cardioangiologica 1989;37(5):251-4. x-wiley/crsRef/3431703
128. De Anna D, Risaliti A, Intini S, Terrosu G, Petri R, Taddeo U, et al. Aminaphtone therapy in venous lymphatic stasis of lower limbs. Phlebologie 1989;2:753-5. x-wiley/crsRef/3431704
129. De Anna D, Risaliti A, Intini S, Uzzau A, Terrosu G, Petri R, et al. Aminaphtone therapy in venous and lymphatic stasis of lower limbs. In: Davy A and Stemmer R, editors(s). Proceedings of the Union Internationale de Phlebologie - 10th World Congress, Strasbourg, 25-29-September 1989. Vol. 2. London and Paris: John Libbey Eurotext Ltd, 1989:753-5. x-wiley/crsRef/3431705
130. Delacroix P. Double-blind trial of endotelon (TM) in chronic venous insufficiency. La Revue de Medecine 1981;22(27-28):1793-802. x-wiley/crsRef/3431707
131. Delecluse M, Ducros JJ, Egal G, Hamel H, Junk R, Leroux A, et al. [Clinical study of Diovenor 300 mg versus a mixture of flavonoides in 90 % of diosmine in the treatment of symptoms of chronic venous insufficiency in young active females]. Essai Clinique Pragmatique de Diovenor 300 mg Versus Melange de Flavonoides a 90 % de Diosmine Dans le Traitement des Manifestations d'Insuffisance Veineuse Chronique Chez la Femme Active Jeune 1991;10(7):498-503. x-wiley/crsRef/3431709
132. de Parades B, Demarez JP, Cauquil J. Comparative analysis of the therapeutic effects of Cyclo 3 Fort and Diosmin 450 mg in combination with hesperidin 50 mg in venous insufficiency of the legs. Vie Medicale 1990;6:226-32. x-wiley/crsRef/3431711
133. De Sanctis MT, Belcaro G, Incandela L, Cesarone MR, Griffin M, Ippolito E, et al. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. Angiology 2001;52(Suppl 2):S55-9. x-wiley/crsRef/3431713
134. Duchene Marullaz P, Amiel M, Barbe R. Evaluation of the clinical pharmacological activity of a phlebotonic agent. Application to the study of Daflon 500 mg. International Angiology 1988;7 Suppl 2:25-32. x-wiley/crsRef/3431715
135. Dustmann HO, Godolias G, Seibel K. Foot volume with chronic venous insufficiency while standing: effect of a new treatment. Therapiewoche 1984;34(36):5077-86. x-wiley/crsRef/3431717
136. Erdlen F. Clinical efficacy of venostasin. A double blind trial. Medizinische Welt 1989;40(36):994-6. x-wiley/crsRef/3431719
137. Erler M. Horse chestnut seed extract in the therapy of the peripheral venous edema - Clinical therapies in comparison. Medizinische Welt 1991;42(7):593-6. x-wiley/crsRef/3431721
138. EudraCT2009-014681-25. Pharmacodynamic and clinical assessment of DC 982 GE (2,4 or 6 capsules per day) in patients with chronic venous disorders: randomised, placebo-controlled, dose effect, double blind, parallel group study. clinicaltrialsregister.eu/ctr-search/search?query=2009-014681-25 (first posted 21 October 2009). x-wiley/crsRef/15204512
139. Forconi S, Guerrini M, Di Perri T. Study of the activity of a flavonoid, O-(beta-hydroxyethyl)-rutoside, at high dose levels of venous tone measured by "strain gauge" plethysmography. Vasa 1977;6(3):279-84. x-wiley/crsRef/3431725
140. Frausini G, Rotatori P, Oliva S. Controlled trial on clinical-dynamic effects of three treatments in chronic venous insufficiency. Giornale Italiano di Angiologica 1985;5(2):147-51. x-wiley/crsRef/3431727
141. Glinski W, Chodynicka B, Roszkiewicz J, Bogdanowski T, Lecewicz-Torun B, Kaszuba A, et al. Effectiveness of a micronized purified flavonoid fraction (MPFF) in the healing process of lower limb ulcers. An open multicentre study, controlled and randomized. Minerva Cardioangiologica 2001;49(2):107-14. x-wiley/crsRef/3431732
142. Glinski W, Chodynicka B, Roszkiewicz J, Bogdanowski T, Lecewicz Torun B, Kaszuba A, et al. The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF) on the healing of leg ulcers: an open, multicentre, controlled, randomised study. Phlebology 1999;14(4):151-7. x-wiley/crsRef/3431731
143. Gonzalez-Fajardo JA, Rodriguez-Camarero SJ, de Marino P, Castro Villamor MA, March Garcia JR, Carpintero Mediavilla L, et al. [Photoplethysmographic evaluation of the effect of a vascular tonic drug]. Angiologia 1990;42(5):167-71. x-wiley/crsRef/3431734
144. Granger C, Laveille C, Vilain C, Jochemsen R. Correlation between haemodynamic parameters of venous tone and clinical symptoms improvement in patients with chronic venous insufficiency. A controlled randomised study of Daflon 200 mg 2 tablets per day versus placebo during two months of treatment. International Angiology 1995;14 Suppl 1:343. x-wiley/crsRef/3431738
145. Henriet JP. [Functional venous insufficiency: clinical study comparing once a day DIOVENOR 600 mg (600 mg of diosmine d'hemisyntheses) versus two doses per day of a mixture of 500 mg of flavonoides (900 mg of diosmine)]. Phlebologie 1995;48(2):285-90. x-wiley/crsRef/3431740
146. Horvath W, Tomschi F. [The postthrombotic state and the effect of dihydroergotamine]. Das Postthrombotische Zustandsbild und Seine Beeinflussung Durch Dihyrdroergotamin 1985;14(1):84-9. x-wiley/crsRef/3431744
147. Incandela L, Cesarone MR, De Sanctis MT, Laurora G, Ricci A, Gerentes I. Evaluation of the microcirculatory effects of veinamitol 3500 mg in chronic venous insufficiency. International Angiology 1995;14 Suppl 1:98-9. x-wiley/crsRef/3431746
148. Incandela L, De Sanctis MT, Cesarone MR, Laurora G, Belcaro G, Taccoen A, et al. Efficacy of troxerutin in patients with chronic venous insufficiency: a double-blind, placebo-controlled study. Advances in Therapy 1996;13(3):161-6. x-wiley/crsRef/3431748
149. Incandela L, Belcaro G, De Sanctis MT, Cesarone MR, Griffin M, Ippolito E, et al. Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. Angiology 2001;52 Suppl 2:S61-7. x-wiley/crsRef/3431750
150. Incandela L, Belcaro G, Renton S, DeSanctis T, Cesarone MR, Bavera P, et al. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. Journal of Cardiovascular Pharmacology and Therapeutics 2002;7 Suppl 1:7-10. x-wiley/crsRef/3431756
151. ISRCTN54360155. A 3 month clinical trial of herbal medicine combination intended for topical application in patients with leg symptoms complaints due to chronic venous insufficiency: a double-blind randomized controlled trial. www.isrctn.com/ISRCTN54360155 (first posted 5 January 2015). x-wiley/crsRef/15204514
152. Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. Journal of Cardiovascular Pharmacology 1999;33(1):7-11. x-wiley/crsRef/3431762
153. Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. Journal of Cardiovascular Pharmacology 1999;33(1):7-11. x-wiley/crsRef/3431764
154. Kalus U, Koscielny J, Grigorov A, Schaefer E, Peil H, Kiesewetter H. Improvement of cutaneous microcirculation and oxygen supply in patients with chronic venous insufficiency by orally administered extract of red vine leaves AS 195: a randomised, double-blind, placebo-controlled, crossover study. Drugs in R & D 2004;5(2):63-71. x-wiley/crsRef/3431769
155. Kalus U, Koscielny J, Grigorov A, Schaefer E, Peil H, Kiesewetter H. Improvement of cutaneous microcirculation and oxygen supply in patients with chronic venous insufficiency by oral therapy with red wine leaf extract AS 195. Vasomed 2004;16(1):20-1. x-wiley/crsRef/3431768
156. Kiesewetter H, Koscielny J, Kalus U, Vix JM, Peil H, Petrini O, et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial. Arzneimittel-Forschung 2000;50(2):109-17. x-wiley/crsRef/3431771
157. Koltringer P, Langsteger W, Klima G, Reisecker F, Eber O. Hemorheologic effects of ginkgo biloba extract EGb 761. Dose- dependent effect of EGb 761 on microcirculation and viscoelasticity of blood. [German]. Fortschritte der Medizin 1993;111(10):170-2. x-wiley/crsRef/3431775
158. Kostering H, Bandura B, Merten HA, Wieding JU. The behaviour of blood clotting and its inhibitors under long-term with 5,6-benzo-alpha-pyrone (coumarin). Double-blind study. Arzneimittel-Forschung 1985;35(8):1303-6. x-wiley/crsRef/3431777
159. Krähenbühl B. Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat). Schweizerische Rundschau fur Medizin Praxis 1975;64(20):632-4. x-wiley/crsRef/3431779
160. Krcílek A, Smejkal V. Therapeutic effects of venotonics in clinical pharmacotherapeutical evaluations by double-blind tests. Casopis Lekaru Ceskych 1973;112:930-3. x-wiley/crsRef/3431783
161. Languillat N, Zucarrelli F. Etude en double aveugle contre placebo de l'activite veinotonique due veliten: evolution de la permeabilite capillare et de lat vitesse de circulation veineuse. Acta Medica Internationale Angiologie 1988;5(83):3-5. x-wiley/crsRef/3431787
162. Languillat N, Zuccarelli F, Hariton C. Radioisotopic comparative double-blind study of venous capillary permeability and circulation rate after treatment by Veliten (R) in venous insufficiency of inferior limbs. In: Proceedings of the Union Internationale de Phlebologie - 10th World Congress, Strasbourg, 25-29 September. 1989. x-wiley/crsRef/3431789
163. Le Dévéhat C, Vimeux M, Bandoux G. Hemoreological effects of oral troxerutin treatment versus placebo in venous insufficiency of the lower limbs. Clinical Hemorrheology 1989;9(4):543-52. x-wiley/crsRef/3431791
164. Le Dévéhat C, Vimeux M, Bondoux G, Khodabandehlou T. Hemorheological effects of oral troxerutin treatment in venous insufficiency of the lower limbs. Phlebologie 1989;2:766-8. x-wiley/crsRef/3431792
165. Le Devehat C, Lemoine A. Effet hemorheological de la troxerutine dans l'insuffisance veineuse [Effet hemorheological de la troxerutine dans l'insuffisance veineuse]. In: Negus D, Jantet G, editors(s). Phlebology 1985. Herts, UK: John Libbey and Co Ltd, 1986:850-2. x-wiley/crsRef/3431793
166. Le Devehat C, Khodabandehlou T, Vimeux M, Kempf C. Evaluation of haemorheological and microcirculatory disturbances in chronic venous insufficiency: activity of Daflon 500 mg. International Journal of Microcirculation: Clinical and Experimental 1997;17(Suppl 1):27-33. x-wiley/crsRef/3431795
167. Marastoni F, Crespi B, Montorsi M, De Stefano A. A clinical and instrumental assessment of the effect of dihydroergotamine in lower extremity venous insufficiency. Archivio per le Scienze Mediche 1982;139(2):165-74. x-wiley/crsRef/3431799
168. Menyhei G, Acsady G, Hetenyi A, Dubeaux D, Rado G. Chronobiology and clinical activity of daflon 500 mg in chronic venous insufficiency. Phlebology 1994;9 Suppl 1:15-8. x-wiley/crsRef/3431803
169. Monteil-Seurin J. Lymphatic venous insufficiency: comparative study of Cyclo 3 Fort (TM) versus diosmin. Comptes Rendus de Therapeutique et de Pharmacologie Clinique 1993;11(109):3-7. x-wiley/crsRef/3431809
170. Morales CA, Barros RM. Efficacy and safety on use of dried horse chestnut extract in the treatment of chronic venous insufficiency of the limbs [Eficácia e segurança do extracto seco da semente de castanha-da-India no tratamento da insuficiencia venosa crônica de membros inferiores]. Revista Brasileira de Medicina 1993;50(11):1563-5. x-wiley/crsRef/3431813
171. Naser-Hijazi B, Gallenkemper G, Rieckemann B, Vanscheidt W. In contrast to its derivatives, coumarin does not influence prothrombin time: results from a randomised placebo-controlled study. Phlebologie 2004;33(1):17-22. x-wiley/crsRef/3431817
172. Schmeck-Lindenau HJ, Naser-Hijazi B, Becker EW, Henneicke von HH, Schnitker J. Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study. International Journal of Clinical Pharmacology and Therapeutics 2003;41(5):193-9. x-wiley/crsRef/3431818
173. NCT01654016. Study of antiinflammatory effects of Detralex (Daflon). https://clinicaltrials.gov/ct2/show/NCT01654016 (accessed 9 September 2015). x-wiley/crsRef/3431820
174. NCT02191163. Efficacy of Antlstax In improving microcirculation of the skin in the leg in patients suffering from chronic venous insufficiency. https://clinicaltrials.gov/ct2/show/NCT02191163 (accessed 9 Sepember 2015). x-wiley/crsRef/3431822
175. NCT02191254. Efficacy and tolerability of Antlstax in male and female patients sufferlng from chronlc venous insufficiency. https://clinicaltrials.gov/ct2/show/NCT02191254 (accessed 9 September 2015). x-wiley/crsRef/3431824
176. NCT02191280. Antistax In patients with chronlc venous insufficiency. https://clinicaltrials.gov/ct2/show/NCT02191280 (accessed 9 September 2015). x-wiley/crsRef/3431826
177. Neumann HAM, Van Den Broek MTJB. Double blind study of the influence of O-(beta-hydroxyethyl)-rutosides on the TcpO2 and LRR curve in patients with chronic venous insufficiency. International Angiology 1988;7(4):9. x-wiley/crsRef/3431828
178. Neuman HAM, Van der Broek MJTB. Evaluation of O-(beta-hydroxyethyl)-rutosides in chronic venous insufficiency by means of non-invasive techniques. Phlebology 1990;5 Suppl 1:13-20. x-wiley/crsRef/3431830
179. Neumann-Mangoldt VP. Treatment of venous disorders of the lower extremities with Essaven-capsules, results of a double blind trial. Fortschritte der Medizin 1979;97(45):2117-20. x-wiley/crsRef/3431835
180. Nill HJ, Fischer H, Nill HJ, Fischer H. Comparative investigations concerning the effect of extract of horse chestnut upon the pressure-volume-diagram of patients with venous disorders. [German]. Arztliche Forschung 1970;24(5):141-3. x-wiley/crsRef/3431837
181. Ottillinger B, Greeske K. Rational therapy of chronic venous insufficiency--chances and limits of the therapeutic use of horse-chestnut seeds extract. BMC Cardiovascular Disorders 2001;1(1):5. x-wiley/crsRef/3431839
182. Paciaroni E, Marini M. Topical therapy for phlebopathies. Results of a controlled clinical study. Policlinico - Sezione Medica 1982;89:255-64. x-wiley/crsRef/3431841 [ID: 8761]
183. Partsch H. Improvement of venous insufficiency with oral dehydroergotamine [Besserung der venosen insuffizienz durch orales dihydroergotamin]. Die Medizinische Welt 1981;32:1668-71. x-wiley/crsRef/3431843
184. Paul V, Lange A. Benzarone in edema of the legs due to chronic venous insufficiency. Munchener Medizinische Wochenschrift 1983;125(16):343-4. x-wiley/crsRef/3431845
185. Pauschinger P. Clinical and experimental examination of the effect of horse-chestnut extract on the transcapillary filtratrion and the intravasel volume in patients with chronic venous insufficiency [Klinisch experimentelle Untersuchungen zur Wirkung von Rosskastanien-samenextrakt auf die transkapilläre Filtration und das intravasale Volumen an Parienten mit chronisch venöser Insuffizienz]. Phlebol Proktol 1987;16:57-61. x-wiley/crsRef/3431847
186. Petruzzellis V, Troccoli T, Candiani C, Guarisco R, Lospalluti M, Belcaro G, et al. Oxerutins (Venoruton): efficacy in chronic venous insufficiency - a double-blind, randomized, controlled study. Angiology 2002;53(3):257-63. x-wiley/crsRef/3431853
187. Pointel JP, Got I, Ziegler OI, Fontaine M, Benedetti F, Drouin P, et al. Double-blind controlled study of a combination of vitamin C, Ruscus aculeatus and Ribes nigrum anthocyanosides on capillary filtration in venous insufficiency [Essai controle en double insu d'une association vitamine C, ruscus aculeatus et anthocyanosides de ribes nigrum sur la filtration capillaire dans l'insuffisance veineuse]. Arteres et veines 1987;6(5):395-7. x-wiley/crsRef/3431855
188. Pokrovskii AV, Sapelkin SV, Galaktionova LA, Fedorov EE. The assessment of medical therapy effectiveness of patients with lower limb chronic venous insufficiency: the results of prospective study with Ginkor Fort. [Russian]. Angiologiia i Sosudistaia Khirurgiia/Angiology and Vascular Surgery 2005;11(3):47-52. x-wiley/crsRef/3431857
189. Questel R, Walrant P. Randomized, placebo-controlled trial of extracts of Ruscus aculeatus and Ribes nigrum plus ascorbic acid in venous insufficiency: Observation of microcirculation by conjunctival capillarography. Gazette Medicale de France 1983;90(6):508-14. x-wiley/crsRef/3431861
190. Rabe E, Stucker M, Esperester A, Schafer E, Ottillinger B. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency - results of a double-blind placebo-controlled study. European Journal of Vascular and Endovascular Surgery 2011;41(4):540-7. x-wiley/crsRef/3431863
191. Riccioni C, Sarcinella R, Izzo A, Palermo G, Liguori M. Effectiveness of Troxerutin in association with Pycnogenol in the pharmacological treatment of venous insufficiency. Minerva Cardioangiologica 2004;52(1):43-8. x-wiley/crsRef/3431871
192. Roztocil K, Prerovsky I, Oliva I. The effect of hydroxyethylrutosides on capillary filtration rate in the lower limb of man. European Journal of Clinical Pharmacology 1977;11:435-8. x-wiley/crsRef/3431875
193. Roztocil K, Stvrtinova V, Strejcek J. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency. International Angiology 2003;22(1):24-31. x-wiley/crsRef/3431877
194. Sanctis MT, Cesarone MR, Incandela L, Belcaro G, Ricci A, Griffin M. Four-week treatment with Essaven gel in diabetic microangiopathy--a placebo-controlled, randomized study. Angiology 2001;52 Suppl 3:S49-55. x-wiley/crsRef/3431881
195. Seydewitz V, Berg D, Staubesand J, Welbers P. Impact of drug treatment on the activity of lysosomal enzymes in the wall of varicose veins [Einflub einer medikamentösen therapie auf die aktivität lysosomaler enzyme in der varikös veränderten Venenwand]. Phlebologie 1992;21(6):288-92. x-wiley/crsRef/3431885
196. Steiner M. Investigation on the edema-reducing and edema-protective effect of horse chestnut seed extract. Phlebol Proktol 1990;19(5):239-42. x-wiley/crsRef/3431893
197. Steiner M. The Extent of the Edema Protective Effect of Horse Chestnut Seed Extract. Vol. 2. Paris: John Libbey Eurotext, 1992. x-wiley/crsRef/3431895
198. Steru D, Steru L. Evaluation clinique d'un phlebotrope: application a l'etude du veinamitol [Evaluation clinique d'un phlebotrope: application a l'etude du veinamitol]. Arteres et Veines 1988;7(4):362-4. x-wiley/crsRef/3431897
199. Topalov Y, Marinov H, Stanchev S. Troxesamol. Clinical application of the preparation in patients with vascular insufficiency of the lower extremities. Medico Biologie Information 1990;4(4):22-5. x-wiley/crsRef/3431903
200. Turio E, Romanelli M, Barachini P. Clinical arid instrumental evaluation of the efficacy of a vasoactive drug containing vitamin PP, vitamin C and phyto-therapeutic extracts titrated in escin, bromelain and anthocyanosides for the treatment of varicose leg ulcers. Giornale Italiano di Dermatologia e Venereologia 2000;135(1):101-5. x-wiley/crsRef/3431907
201. Weindorf N, Schultz Ehrenburg U. Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone. Zeitschrift fur Hautkrankheiten 1987;62:28-38. x-wiley/crsRef/3431909
202. Widmer LK, Glaus L, Raps E. Local treatment of leg disorders and chronic venous insufficiency. Double blind study of 55 patients. Schweizerische Rundschau fur Medizin Praxis 1972;61(42):1300-4. x-wiley/crsRef/3431911
203. Zuccarelli F. Evaluation of the effectiveness of Ginkor Fort on the symptoms of chronic venous insufficiency. Phlébologie 1996;49(1):105-10. x-wiley/crsRef/3431915
204. Barattini DF, Dogaru DE. Clinical trial to assess the efficacy of μSmin® Plus. clinicaltrials.gov/ct2/show/NCT04101201 (first posted 24 September 2019). x-wiley/crsRef/15204516
205. ISRCTN18841175. Effects of micronised purified flavonoic fraction on microcirculation in women suffering from chronic venous disease. www.isrctn.com/ISRCTN18841175 (first posted 20 July 2009). x-wiley/crsRef/3431917
206. NCT01532882. Efficacy and safety of Diosmin 600mg versus placebo on painful symptomatology in patients with chronic venous disease of lower limbs (EDEN). clinicaltrials.gov/show/NCT01532882 (first posted 15 Febraury 2012). x-wiley/crsRef/3431919
207. NCT03833024. The MUFFIN-PTS Trial (MUFFIN-PTS). clinicaltrials.gov/ct2/show/NCT03833024 (first posted 6 February 2019). x-wiley/crsRef/15204518
208. Agencia Española del Medicamento (2002). Re-evaluation of the risk-benefit relationship of oral phlebotonic agents [Re-evaluación de la relación beneficio-riesgo de los agentes flebotónicos para administración por via oral]. https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2002/ni_2002-09_flebotonicos/ (accessed 27 March 2020).
209. Anatomical Therapeutic Chemical (ATC) system classification. http://www.whocc.no/atc_ddd_index/?code=C05 (accessed December 2015).
210. Aziz Z, Tang WL, Chong NJ, Tho LY. A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency. Journal of Clinical Pharmacy and Therapeutics 2015;40(2):177-85.
211. Behar A, Lagrue G, Cohen-Boulakia F, Baillet J. Capillary filtration in idiopathic cyclic edema - effects of Daflon 500 mg. Nuklearmedizin 1988;27(3):105-7.
212. Boada JN, Nazco GJ. Therapeutic effect of venotonics in chronic venous insufficiency. A meta-analysis. Clinical Drug Investigation 1999;18(6):413-32.
213. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. American Journal of Preventive Medicine 1988;4(2):96-101.
214. Carpentier PH. Epidemiology and physiopathology of chronic venous leg diseases. Revue du Praticien 2000;50(11):1176-81.
215. Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G, et al. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study. Clinical and Applied Thrombosis/Hemostasis 2006;12(2):205-12.
216. Ciapponi A, Laffaire E, Roque M. Calcium dobesilate for chronic venous insufficiency: a systematic review. Angiology 2004;55(2):147-54.
217. Clarke M, Oxman AD, editors. Cochrane Reviewers’ Handbook [updated March 2003]. Oxford, UK: The Cochrane Library. The Cochrane Collaboration. Update Software; Issue 2, 2003.
218. Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
219. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
220. Diehm C. The role of oedema protective drugs in the treatment of chronic venous insufficiency: a review of evidence based on placebo-controlled clinical trials with regard to efficacy and tolerance. Phlebology 1996;11(1):23-9.
221. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al, American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. Journal of Vascular Surgery 2004;40(6):1248-52.
222. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. Journal of Epidemiology and Community Health 1999;53(3):149-53.
223. McMaster University GRADEpro Version 3.2 for Windows [GRADEpro. www.gradepro.org].]. Brozek J, Oxman A, Schünemann H. Ontario, Canada: McMaster University, 2008.
224. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
225. Ibañez L, Ballarín E, Vidal X, Laporte JR. Agranulocytosis associated with calcium dobesilate. Clinical course and risk estimation with the case-control and the case-population approaches. European Journal of Clinical Pharmacology 2000;56(9-10):763-7.
226. Ibáñez L, Vidal X, Ballarín E, Laporte JR. Population-based drug-induced agranulocytosis. Archives of Internal Medicine 2005;165(8):869-74.
227. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996;17(1):1-12.
228. Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms,signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol 2018;37:143-54.
229. Kaufman DW, Kelly JP, Levy Shapiro S. The Drug Etiology of Agranulocytosis and Aplastic Anemia. New York: Oxford University Press, 1991.
230. Kurz X, Kahn SR, Abenhaim L, Clement D, Norgren L, Baccaglini U, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. International Angiology 1999;18(2):83-102.
231. Lefebvre C, Manheimer E, Glanville J. Chapter 6. Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org 2011.
232. Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, et al. The 2020 update of the CEAP classification system and reporting standards. Journal of Vascular Surgery 2020;8(3):342-352.
233. Markwardt F. Pharmacology of oedema protective drugs. Phlebology 1996;11(1):10-5.
234. Nicolaides AN Cardiovascular Disease Educational and Research Trust European Society of Vascular Surgery The International Angiology Scientific Activity Congress Organization International Union of Angiology Union Internationale de Phlebologie at the Abbaye des Vaux de Cernay. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation 2000;102(20):E126-63.
235. Pittler MH, Ernst E. Horse-Chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Archives of Dermatology 1998;134(11):1356-60.
236. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No: CD003230. [DOI: 10.1002/14651858.CD003230.pub4]
237. Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. Journal of Vascular Surgery 1995;21(4):635-45.
238. Poynard T, Valterio C. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency. Vasa 1994;23(3):244-50.
239. Rabe E, Guex JJ, Morrison N, Ramelet AA, Schuller-Petrovic S, Scuderi A, et al. Treatment of chronic venous disease with flavonoids: recommendations for treatment and further studies. [Review]. Phlebology 2013;28(6):308-19.
240. Robertson LA, Evans CJ, Lee AJ, Allan PL, Ruckley CV, Fowkes FG. Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study. European Journal of Vascular and Endovascular Surgery 2014;48(2):208-14.
241. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and “Summary of findings” tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of interventions Version 5.1.0. London, UK: The Cochrane Collaboration. www.cochrane-handbook.org, 2011.
242. Scott TE, LaMorte WW, Gorin DR, Menzoain JO. Risk factors for chronic venous insufficiency: a dual case-control study. Journal of Vascular Surgery 1995;22(5):622-8.
243. Stanhope JM. Varicose veins in a population of New Guinea. International Journal of Epidemiology 1975;4(3):221-5.
244. Tsouredos Y. Venous tone: are the phlebotonics properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg. Zeitschrift fur Kardiologie 1991;80 Suppl 7:95-101.
245. Van den Oever R, Hepp B, Debbaut B, Simon I. Socio-economic impact of chronic venous insufficiency. An underestimated public health problem. International Angiology 1998;17(3):161-7.
246. Vasquez MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. Journal of Vascular Surgery 2010;52(5):1387-96.
247. Venous Forum of the Royal Society of Medicine, Berridge D, Bradbury AW, Davies AH, Gohel M, Nyamekye I, et al. Recommendations for the referral and treatment of patients with lower limb chronic venous insufficiency (including varicose veins). Phlebology 2011;26(3):91-3.
248. Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology and therapeutic efficacy in venous insufficiency and related disorders. Drugs 1992;44(6):1013-32.
249. Martinez MJ, Bonfill X, Moreno RM, Cachà A, Vargas E, Capellà D. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No: CD003229. [DOI: 10.1002/14651858.CD003229]
250. Martinez-Zapata MJ, Bonfill Cosp X, Moreno RM, Vargas E, Capellà D. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No: CD003229. [DOI: 10.1002/14651858.CD003229.pub2]
251. Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, Capellà D, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No: CD003229. [DOI: 10.1002/14651858.CD003229.pub3]